Irregular Astigmatism Clinical Study

If you have irregular astigmatism you may qualify for a clinical study to evaluate various designs of the ClearKone® hybrid contact lens with a new silicone hydrogel skirt designed to improve vision.

Log In

Search our site

ClearKone® Lense Care and Handling

Click here to learn how to handle and care for your ClearKone lenses.

This news section is designed to aggregate online, magazine and newspaper articles written about keratoconus.


SynergEyes, Inc. Sponsors the National Keratoconus Foundation

San Diego, CA (March 22, 2011) – SynergEyes, Inc., the leader in hybrid contact lens technology, announced that it will continue to be a major sponsor of the National Keratoconus Foundation (NKCF), a Patient Outreach and Education Program of the non-profit organization Discovery Eye Foundation, with a contribution of $20,000.

As the inventor of the first hybrid contact lens with FDA-clearance specifically designed for patients with keratoconus, SynergEyes supports the mission of the NKCF to improve the quality of life of persons with keratoconus by making educational material available to them, their families and their eye care professionals.

The ClearKone® lens by SynergEyes is specifically designed to restore vision to patients with keratoconus and other types of corneal irregularities.  Because the lens vaults over the cornea, there’s minimal risk of corneal scarring, making ClearKone® a healthy treatment option for keratoconus.  In addition, the soft skirt of the ClearKone® design provides all-day comfort …


Category: News

SynergEyes Grants Life Changing Gift for Holidays: Ability to Distinguish Family Faces Keratoconus Patients Granted New Hybrid Contact Lens Technology

Carlsbad, CA (December 20, 2010) – This holiday season patients are receiving the life-changing gift of clear and comfortable vision thanks to the Sharing Vision Grant Program sponsored by SynergEyes, Inc. This program was created to bring the new technologically advanced ClearKone® hybrid contact lens to keratoconus patients who may otherwise not have access.  Keratoconus is a degenerative eye disease that occurs 1 in 1,000 people causing substantially distorted vision and in many cases changes how they live their lives. Patients can apply for the program on at www.TreatKeratoconus.com.

Cassidy Randle was a successful college student looking to go to nursing school, after graduation. Just as any young girl, she wanted to get rid of her glasses and therefore underwent refractive eye surgery in 2003. Initially her vision was okay and then it started deteriorating. In no time she was almost blind in her left eye and had poor vision in …


Category: News

Free Keratoconus Patient Education Seminar – Saturday December 3rd, 2011

NEW JERSEY KC PATIENT EDUCATION SEMINAR
The Cornea and Laser Eye Institute in conjunction with the National Keratoconus Foundation, will be hosting a Keratoconus Educational Seminar.
At the seminar, scientists and clinicians will provide an overview of keratoconus and outline recent scientific breakthroughs, with particular focus on new contact lens designs, KC and allergies and dry eye issues, corneal crosslinking, corneal ring inlays and new corneal reshaping techniques, and an update on corneal transplant procedures.

This is a free seminar, but registration is required.
For more information and to register call 201-883-0505 or email Stacey Lazar, e-mail slazar@vision-institute.com.
 
Saturday December 3rd, 2011

9 a.m. ~ 2 p.m. (Registration at 8:30 a.m.)

GLENPOINTE MARRIOTT
100 Frank W. Burr Blvd.
Teaneck, New Jersey

Category: News

Thermo-biomechanical system gets CE mark

Article published in Ophthalmology Times

Waltham, MA—A thermo-biomechanical system (Vedera, Avedro) for performing a proprietary procedure (Keraflex) to flatten the cornea in the treatment of myopia and keratoconus has received the European Union (EU) CE mark.

“CE mark certification is an important milestone for the company and also represents a vital new offering to ophthalmic patients and their physicians,” said David Muller, PhD, president and chief executive officer of Avedro.

Through the noninvasive, incisionless procedure performed by the device, the cornea is thermally remodeled without the removal of any tissue, thereby inducing refractive change without weakening the cornea’s biomechanical integrity.

In its European clinical trials for the correction of myopia and the treatment of keratoconus, the company has investigated a two-step procedure whereby the cornea is flattened to achieve refractive correction while concomitant collagen crosslinking stabilizes the cornea.

“The . . . procedure, by thermally altering the tension of collagen fibers, induces a corneal flattening …


Category: News

Copyright 2008-© 2010-2011 SynergEyes® Inc. All rights reserved.
Website Design by Gravity Station